Bogos Agianian

Title: The Innovations of Bogos Agianian

Introduction

Bogos Agianian is a notable inventor based in Bayside, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit RAF dimers. His work is crucial in the fight against various types of cancer.

Latest Patents

Agianian holds a patent for "Compounds useful for inhibiting RAF dimers." This patent includes compounds of Formula I and their pharmaceutically acceptable salts. The compounds are designed to inhibit RAF kinase dimerization, which is essential for the functioning of both wild type and mutant BRAF kinases. The patent also covers pharmaceutical compositions that include these compounds and methods for treating cancers susceptible to BRAF dimerization inhibitors. These cancers include melanoma, thyroid cancer, hairy cell leukemia, ovarian cancer, lung cancer, and colorectal cancer.

Career Highlights

Agianian is affiliated with the Albert Einstein College of Medicine, where he conducts research and develops innovative solutions for cancer treatment. His work has the potential to impact many patients suffering from various forms of cancer.

Collaborations

Agianian collaborates with Evripidis Gavathiotis, a fellow researcher, to further advance their work in cancer treatment.

Conclusion

Bogos Agianian's contributions to the field of pharmaceuticals and cancer treatment through his innovative patents highlight the importance of research and collaboration in addressing critical health challenges. His work continues to pave the way for new therapeutic options for patients in need.